JPRN-UMIN000019457
Completed
N/A
Effects of Dapagliflozin on 24-h Glycemic Changes in Japanese Patients with type 2 Diabetes Mellitus (T2DM), who Receives Basal supported Oral Therapy - DBOT
Tokushima University Graduate School0 sites36 target enrollmentNovember 1, 2015
Conditionstype 2 diabetes mellitus (T2DM)
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- type 2 diabetes mellitus (T2DM)
- Sponsor
- Tokushima University Graduate School
- Enrollment
- 36
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Type 1 diabetes mellitus, secondary diabetes mellitus 2\. 3\. Patients who have complications of severe hepatic disease , severe renal disease or receiving dialysis or recent 5 years malignancies. Patients with cardiovascular diseases (recent cardiovascular events, congestive heart failure, patients with uncontrolled high blood pressure) 4\. Volume depleted patients (the study intends to enroll elderly patients over 65 who are more prone to volume depletion due to co\-existing conditions and concomitant medications such as loop diuretics) 5\. Patients with pregnancy, possible pregnancy, or on breast\-feeding 6\. Contraindication for the use of dapagliflozin 7\. Patients who were received other sodium glucose cotransporter 2 inhibitor 8\. Disqualified from the study by the primary investigator or a sub\-investigator for any reason other than given above.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or InsulinType II DiabetesNCT02429258AstraZeneca226
Completed
Phase 4
Effect of Dapagliflozin on Glycemic VariabilityType 2 Diabetes MellitusNCT02459353The Catholic University of Korea86
Completed
Phase 3
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseType 2 Diabetes MellitusCardiovascular DiseaseInadequate Glycaemic ControlNCT01042977AstraZeneca964
Completed
N/A
The investigation of the effectiveness by dapagliflozin on severity of sleep disorder breathing (SDB) among the Japanese patients with type 2 diabetes mellitusJapanese patients with type2 diabetes mellitusJPRN-UMIN000018592Department of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine30
Not Yet Recruiting
Phase 4
Dapagliflozin in Acute Heart failureIRCT20220529055013N1Public Sector medical University160